Comprehensive Regulatory Strategy

Navigating the Path of Least Resistance.

The Regulatory Shield

Regulatory approval is not an afterthought; it is the foundation of our process. Led by RAC-certified experts, we construct defensible submission strategies that withstand FDA scrutiny. We treat compliance as a competitive advantage, ensuring your submission is right the first time to avoid costly “Requests for Additional Information.”

What We Offer?

510(k), PMA, and De Novo Pathways
Strategic mapping of the optimal submission route to clear the FDA with minimal friction.
Pre-Submission (Q-Sub) Management
Managing formal interactions with the FDA to gain early alignment on clinical and testing expectations.
Clinical Evaluation Reports (CER)
Comprehensive data analysis and literature reviews to prove clinical safety and performance.
Post-Market Surveillance (PMS) Plans
Building the infrastructure to monitor device performance and maintain compliance long after the launch.
Expert guidance in navigating the complex shift from MDD to the more rigorous MDR requirements in Europe.
Strategic mapping of the optimal submission route to clear the FDA with minimal friction.

Regulatory Planning

Early Concept Design & Development
Regulatory Strategy
QMS Implementation
Project Development & Precision Manufacturing
Supply Chain & Logistics

Get a free consultation?

Our Head Regulatory Consultant

Kelsey Lee

Over 16 Years working with the FDA : You don't want your dream in anyone else's hands.

First-Time Clearance

Strategic submissions that eliminate AI requests

Scalable QMS Architecture

Built for startups, ready for enterprise

Cutting Edge Design without the Stress

Close

Our approach is straightforward— We engineer bold, defensible regulatory strategies that push your device through the FDA and into the field.

WANT IT TO SOUND PLAYFUL, LUXURIOUS, OR MORE/